The Moral Limits to Federal Funding for Kidney Disease
Bibliographic Data
| ID | 20338407 |
|---|---|
| Authors | John C Moskop (0000-0001-7627-2801, East Carolina University, corresponding author) |
| Year | 1987 |
| Volume | 17 |
| Issue | 2 |
| Pages | 11 |
| Publication date | 1987-04-01 |
| Peer Reviewed | Yes |
| Open Access | No |
| Type | ARTICLE |
| Venue | The Hastings Center Report (JOURNAL) |
| Journal identifiers | ISSN: 0093-0334 • E-ISSN: 1552-146X |
| Publisher | JSTOR (PUBLISHER) |
| DOI | 10.2307/3562035 |
| PMID | 3294741 |
| OpenAlex | W2064195640 |
| Language | EN |
| Citations received | 2 |
In the current era of cost-containment, Congress may reconsider its support for the End-Stage Renal Disease Program. Substantial reductions in funding for this program could be made by eliminating non-beneficial, marginally beneficial, and relatively inefficient modes of treatment. These measures, however, will only postpone the inevitable day when clearly beneficial treatment must be withheld
Actuarial science · Business · Disease · Economics · Intensive care medicine · Political science · Public economics · Healthcare cost, quality, practices · Healthcare Policy and Management · Internal Medicine · Medicine · Organ Donation and Transplantation
| Unique citing works | 2 |
|---|---|
| Citations per year | 0.05 |
| Citation span | 1988 - 1993 (6) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 1 |